Progress in Cartilage Tissue Engineering with Nanostructured Extracellular Matrix


Article Preview

Tissue defects and organ failure have seriously threatened the health and life of human beings and are challenges in modern medicine we have been trying to overcome. They are often treated with tissue and organ transplantation. Although autologous tissue transplantation is not bothered by immune rejection, it could cause defects of the donor site and create new pains. Therefore, scientists are striving to explore more ideal principles and methods while working hard to improve the existing treatments as most as possible. The rise and development of tissue engineering will be possible to provide adequate safe “autologous” tissues and organs to repair human body. Cartilage damage is one of the main causes of osteoarthritis. However, it has limited self-repair ability. Thus, cartilage tissue engineering, especially nanomaterials as a new treatment modality provides a therapeutic potential.



Edited by:

Helen Zhang, David Jin and X.J. Zhao




Y. Li et al., "Progress in Cartilage Tissue Engineering with Nanostructured Extracellular Matrix", Advanced Materials Research, Vol. 643, pp. 144-148, 2013

Online since:

January 2013




[1] Baumgaertner MR, Canon WD, Vittori JM, et al. Arthroscopic debridement of the arthritic knee. Clin Othop Relat Res. 1990; 253: 197-202.

[2] Rand JA. Role of arthroscopy in osteoarthritis of the knee. Arthroscopy. 1991; 7: 358-363.

[3] Timony JM, Kneisl JS, Barrack RL, et al. Arthroscopy update: 6 arthroscopy in the osteoarthritic knee. Long-term follow-up. Orthop Rev. 1990; 19: 371-373.

[4] Homminga GN, Bulstra SK, Bouwmeester PS, et al. Perichondral grafting for cartilage lesions of the knee. J Bone Jt Surg Am. 1990; 72B: 1003-1007.

[5] Green WT Jr. Articular cartilage repair. Behavior of rabbit chondrocytes during tissue culture and subsequent allografting. Clin Orthop Relat Res. 1977 , (124): 237-250.


[6] Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell (Cambridge Mass). 1982; 30: 215-224.


[7] Wakitani S, Kimura T, Hirooka A, et al. Repari of rabbit articular surffaces with allografts of chondrocytes embedded in collagen gels. Nippon Seikeigeka Gakkai Zasshi. 1989; 63: 529-538.

[8] Lee CR, Grodzinsky AJ, Hsu HP, et al. Effects of harvest and selected cartilage repair procedures on physical and biochemical properties of articular cartilage in the canine knee. J Orthop Res. 2000; 18: 790-799.


[9] Buckwalter JA, Lohmanders S. Operative treatment of osteoarthrosis. Current practice and future development. J Bone Jt Surg Am. 1994; 76A: 1405-1418.

[10] Rodrigo JJ, Steadman JR, Silliman JF, et al. Improvement of full-thickness chondral defect healing in the human knee after debridement and microfracture using continuous passive motion. Am J Knee Surg. 1994; 7: 109-116.

[11] Gao J, Dennis JE, Solchaga LA, et al. Repair of osteochondral defect with tissue-engineered two-phase composite material of injectable calcium phosphate and hyaluronan sponge. Tissue Eng. 2002; 8: 827-837.


[12] Schek RM, Taboas JM, Segvich SJ, et al. Engineered osteochondral grafts using biphasic composite solid free-form fabricated scaffolds. Tissue Eng. 2004; 10: 1376-1385.


[13] Kotobuki N, Ioku K, Kawagoe D, et al. Observation of osteogenic differentiation cascade of living mesenchymal stem cells on transparent hydroxy apatite ceramics. Biomaterials. 2005; 26: 779-785.


[14] Kasten P, Vogel J, Luginbuhl R, Niemeyer P, et al. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxy apatite carrier. Biomaterials. 2005; 26: 5879-5889.


[15] Martin JA, Buckwalter JA. Articular cartilage aging and degeneration. Sports Med Arthroscopy Rev. 1996; 4: 263-275.

[16] Fortier LA, Lust G, Nixon AJ. Insulin-like growth factor-I enhances cell-based articular cartilage resurfacing. Trans 45th Annu Meet Orthop Res Soc. 1999; P58.

[17] Jonstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238: 265-272.

[18] Jonstone B, Yoo JU. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Ortop Relat Res. 1999; 367S: 156-162.

[19] Denker AE, Haas AR, Nicoll SB, et al. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differntiation (Berlin). 1999; 64: 67-76.


[20] Stone K.R., Steadman J.R., Rodkey W.G., et al. Regeneration of meniscal cartilage with use of a collagen scaffold. Analysis of preliminary data. J Bone Joint Surg Am, 1997, 79(12): 1770-1777.


[21] Kim JY, Khang D, Lee JE, et al. Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane. J Biomed Mater Res A. 2009, 88(2): 419-426.


[22] Hsu SH, Huang TB, Cheng SJ et al. Chondrogenesis from human placenta-derived mesenchymal stem cells in three-dimensional scaffolds for cartilage tissue engineering. Tissue Eng Part A. 2011, 17(11-12): 1549-1560.


[23] Lin HR, Ling MH, Lin YJ. High strength and low friction of a PAA-alginate-silica hydrogel as potential material for artificial soft tissues. J Biomater Sci Polym Ed. 2009, 20(5-6): 637-652.


[24] Xue D, Zheng Q, Zong C et al. Osteochondral repair using porous poly(lactide-co-glycolide)/ nano-hydroxyapatite hybrid scaffolds with undifferentiated mesenchymal stem cells in a rat model. J Biomed Mater Res A, 2010, 94(1): 259-270.


[25] Kon E, Delcogliano M, Filardo G et al. Novel nano-composite multilayered biomaterial for osteochondral regeneration: a pilot clinical trial. Am J Sports Med. 2011, 39(6): 1180-1190.